CVS Health (CVS)
(Delayed Data from NYSE)
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
Zacks News
3 REITs for Dividend Investors to Buy with Stock Market at New Highs
by Benjamin Rains
Here are three highly-ranked REITs we found using our Zacks Stock Screener that dividend investors might want to buy with stock indexes at new highs...
Here's Why You Should Hold on to CVS Health (CVS) For Now
by Zacks Equity Research
Investors can still hold on to CVS Health (CVS) stock, thanks to its solid prospects.
Walgreens Boots Rallies on KKR's Bid but Market View Mixed
by Urmimala Biswas
Albeit the market sentiment is bullish on Walgreens Boots' (WBA) potential acquisition deal, many analysts are in doubt about the company's effective approach to get privatized.
CVS Health's New Plans With Aetna May Improve Health Outcomes
by Zacks Equity Research
CVS Health's (CVS) Health Care Benefits segment develops Medicare program with Aetna.
Want To Retire Early? Learn the Intelligent Investing Secret - November 13, 2019
by Zacks Equity Research
Accomplishing the financial cushion to retire early is a fantasy for most, but bringing that fantasy to reality is not as difficult as it sounds. If you are willing to make some serious lifestyle adjustments, it can be achievable.
CVS Health's Aetna Prospects Solid, Omnicare Sluggish
by Zacks Equity Research
CVS Health's (CVS) strong Pharmacy Services segment sales gain traction from growth in specialty services.
The Zacks Analyst Blog Highlights: Mastercard, UnitedHealth, Merck, Qualcomm and CVS Health
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Mastercard, UnitedHealth, Merck, Qualcomm and CVS Health
Top Analyst Reports for Mastercard, UnitedHealth & Merck
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Mastercard (MA), UnitedHealth Group (UNH) and Merck (MRK).
Stock Market News for Nov 7, 2019
by Zacks Equity Research
Wall Street moved negligibly on Nov 6 as stocks struggled to sustain the rally earlier in the week.
The Extreme Risks of Trading Your Own Retirement Assets - November 07, 2019
by Zacks Equity Research
From understanding your risk tolerance to maintaining emotional control, achieving your retirement goals takes a much different investing approach than regular stock trading.
CVS Health (CVS) Beats on Q3 Earnings, Raises '19 EPS Guidance
by Zacks Equity Research
CVS Health's (CVS) strong year-over-year growth in the top line is aided by a robust performance at the Pharmacy Services segment.
Economic Data Deluge
by Zacks Equity Research
Economic Data Deluge
Q3 Productivity Slips to -0.3%, Labor Costs Rise 3.6%
by Mark Vickery
To see a negative headline read on U.S. Productivity is thankfully quite rare. The last time we saw this was nearly 4 full years ago.
CVS Health (CVS) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 3.95% and 2.83%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
New Highs, Uber Stock & Buy Boston Beer on Hard Seltzer Growth - Free Lunch
by Benjamin Rains
U.S. stock indexes hit new highs amid U.S.-China trade war progress. Quarterly earnings results, including Uber. The episode then closes with a look at why The Boston Beer Company (SAM) is a Zacks Rank #1 (Strong Buy) stock...
Dropbox (DBX) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Dropbox (DBX) continuous efforts to strengthen cloud-based and AI technologies are likely to have driven the top line in the third quarter.
Easy Investing Secrets to an Early Retirement - November 05, 2019
by Zacks Equity Research
Achieving the financial freedom to retire early is a dream for most, but making that dream a reality isn't as tricky as it sounds. If you are willing to make some serious lifestyle changes and sacrifices, it can be possible.
Can Pharmacy Services Drive CVS Health's (CVS) Q3 Earnings?
by Zacks Equity Research
CVS Health's (CVS) Caremark legacy business is expected to have delivered a solid third quarter, backed by the company's robust execution of its formulary and cost-containment tools.
Insight (NSIT) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Insight's (NSIT) third-quarter results are likely to have been driven by its balanced portfolio of customer end-markets, and broad product and solutions pipeline.
ANSYS (ANSS) Gears Up for Q3 Earnings: What's in Store?
by Zacks Equity Research
ANSYS' (ANSS) robust demand for simulation software solutions, particularly from automotive end-market, is likely to drive the third-quarter top line.
Can All-Line Growth Boost CVS Health's (CVS) Q3 Earnings?
by Zacks Equity Research
The newly-incorporated Health Care Benefits business already registers top-line contributions for CVS Health (CVS).
4 Retail Stocks Likely to Outshine This Earnings Season
by Sumit Singh
Retailers are making prudent investments to strengthen digital ecosystem and delivery capabilities. While these drive sales, they entail high costs. Margins remain a key area to watch this reporting cycle.
CVS Health (CVS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Extreme Risks of Trading Your Own Retirement Assets - October 30, 2019
by Zacks Equity Research
From understanding your risk tolerance to maintaining emotional control, achieving your retirement goals takes a much different investing approach than regular stock trading.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $65.88 in the latest trading session, marking a +1.2% move from the prior day.